Stanley Druckenmiller's TEVA Position Overview
Stanley Druckenmiller (via Duquesne Family Office LLC) currently holds 16.6M shares of Teva Pharmaceutical Industries Limited (TEVA) worth $335.2 M, representing 8.25% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Stanley Druckenmiller has maintained a long-term strategic position in TEVA, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2024, adding 7.6M shares. Largest reduction occurred in Q1 2015, reducing 450.5K shares.
Analysis based on 13F filings available since 2013 Q2
Stanley Druckenmiller's Teva Pharmaceutical Industries Limited (TEVA) Holding Value Over Time
Track share changes against reported price movement
Quarterly Teva Pharmaceutical Industries Limited (TEVA) Trades by Stanley Druckenmiller
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2013 | +1.24 M | New Buy | 1.24 M | $40.08 |
| Q3 2014 | -1.24 M | Sold Out | 1.24 M | $0.00 |
| Q1 2015 | +790,500 | New Buy | 790,500 | $62.30 |
| Q2 2015 | -790,500 | Sold Out | 790,500 | $0.00 |
| Q3 2024 | +1.43 M | New Buy | 1.43 M | $18.02 |
| Q4 2024 | +7.57 M | Add 530.09% | 9 M | $22.04 |
| Q1 2025 | +5.88 M | Add 65.38% | 14.88 M | $15.37 |
| Q2 2025 | +1.09 M | Add 7.32% | 15.97 M | $16.76 |
| Q3 2025 | +625,000 | Add 3.91% | 16.59 M | $20.20 |
Stanley Druckenmiller's Teva Pharmaceutical Industries Limited Investment FAQs
Stanley Druckenmiller first purchased Teva Pharmaceutical Industries Limited (TEVA) in Q4 2013, acquiring 1,241,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller has held Teva Pharmaceutical Industries Limited (TEVA) for 48 quarters since Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller's largest addition to Teva Pharmaceutical Industries Limited (TEVA) was in Q4 2024, adding 8,997,400 shares worth $198.3 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Stanley Druckenmiller's firm, Duquesne Family Office LLC, owns 16,593,935 shares of Teva Pharmaceutical Industries Limited (TEVA), valued at approximately $335.2 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Teva Pharmaceutical Industries Limited (TEVA) represents approximately 8.25% of Stanley Druckenmiller's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Stanley Druckenmiller's peak holding in Teva Pharmaceutical Industries Limited (TEVA) was 16,593,935 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.